English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 107 | Tables: 101 | Medical Care
The global Optogenetic Retinal Gene Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Optogenetic Retinal Gene Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Optogenetic Retinal Gene Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Optogenetic Retinal Gene Therapy in Neurological Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Optogenetic Retinal Gene Therapy include Bionic Sight, Nanoscope Therapeutics, GenSight Biologics, Allergan, Ray Therapeutics, Novartis, UgeneX, GenAns Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Optogenetic Retinal Gene Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Optogenetic Retinal Gene Therapy. The Optogenetic Retinal Gene Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Optogenetic Retinal Gene Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Optogenetic Retinal Gene Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bionic Sight
Nanoscope Therapeutics
GenSight Biologics
Allergan
Ray Therapeutics
Novartis
UgeneX
GenAns Biotechnology
Segment by Type
Light Sensitive Protein
Light Sensitive Protein Transporter
Light Stimulation System
Segment by Application
Neurological Diseases
Retinal Diseases
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Optogenetic Retinal Gene Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Optogenetic Retinal Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Light Sensitive Protein
1.2.3 Light Sensitive Protein Transporter
1.2.4 Light Stimulation System
1.3 Market by Application
1.3.1 Global Optogenetic Retinal Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurological Diseases
1.3.3 Retinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Optogenetic Retinal Gene Therapy Market Perspective (2021–2032)
2.2 Global Optogenetic Retinal Gene Therapy Growth Trends by Region
2.2.1 Global Optogenetic Retinal Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Optogenetic Retinal Gene Therapy Historic Market Size by Region (2021–2026)
2.2.3 Optogenetic Retinal Gene Therapy Forecasted Market Size by Region (2027–2032)
2.3 Optogenetic Retinal Gene Therapy Market Dynamics
2.3.1 Optogenetic Retinal Gene Therapy Industry Trends
2.3.2 Optogenetic Retinal Gene Therapy Market Drivers
2.3.3 Optogenetic Retinal Gene Therapy Market Challenges
2.3.4 Optogenetic Retinal Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Optogenetic Retinal Gene Therapy Players by Revenue
3.1.1 Global Top Optogenetic Retinal Gene Therapy Players by Revenue (2021–2026)
3.1.2 Global Optogenetic Retinal Gene Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Optogenetic Retinal Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Optogenetic Retinal Gene Therapy Revenue
3.4 Global Optogenetic Retinal Gene Therapy Market Concentration Ratio
3.4.1 Global Optogenetic Retinal Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optogenetic Retinal Gene Therapy Revenue in 2025
3.5 Global Key Players of Optogenetic Retinal Gene Therapy Head Offices and Areas Served
3.6 Global Key Players of Optogenetic Retinal Gene Therapy, Products and Applications
3.7 Global Key Players of Optogenetic Retinal Gene Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Optogenetic Retinal Gene Therapy Breakdown Data by Type
4.1 Global Optogenetic Retinal Gene Therapy Historic Market Size by Type (2021–2026)
4.2 Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Type (2027–2032)
5 Optogenetic Retinal Gene Therapy Breakdown Data by Application
5.1 Global Optogenetic Retinal Gene Therapy Historic Market Size by Application (2021–2026)
5.2 Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Optogenetic Retinal Gene Therapy Market Size (2021–2032)
6.2 North America Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Optogenetic Retinal Gene Therapy Market Size by Country (2021–2026)
6.4 North America Optogenetic Retinal Gene Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Optogenetic Retinal Gene Therapy Market Size (2021–2032)
7.2 Europe Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Optogenetic Retinal Gene Therapy Market Size by Country (2021–2026)
7.4 Europe Optogenetic Retinal Gene Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size (2021–2032)
8.2 Asia-Pacific Optogenetic Retinal Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Optogenetic Retinal Gene Therapy Market Size (2021–2032)
9.2 Latin America Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2021–2026)
9.4 Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size (2021–2032)
10.2 Middle East & Africa Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bionic Sight
11.1.1 Bionic Sight Company Details
11.1.2 Bionic Sight Business Overview
11.1.3 Bionic Sight Optogenetic Retinal Gene Therapy Introduction
11.1.4 Bionic Sight Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.1.5 Bionic Sight Recent Development
11.2 Nanoscope Therapeutics
11.2.1 Nanoscope Therapeutics Company Details
11.2.2 Nanoscope Therapeutics Business Overview
11.2.3 Nanoscope Therapeutics Optogenetic Retinal Gene Therapy Introduction
11.2.4 Nanoscope Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.2.5 Nanoscope Therapeutics Recent Development
11.3 GenSight Biologics
11.3.1 GenSight Biologics Company Details
11.3.2 GenSight Biologics Business Overview
11.3.3 GenSight Biologics Optogenetic Retinal Gene Therapy Introduction
11.3.4 GenSight Biologics Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.3.5 GenSight Biologics Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Optogenetic Retinal Gene Therapy Introduction
11.4.4 Allergan Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.4.5 Allergan Recent Development
11.5 Ray Therapeutics
11.5.1 Ray Therapeutics Company Details
11.5.2 Ray Therapeutics Business Overview
11.5.3 Ray Therapeutics Optogenetic Retinal Gene Therapy Introduction
11.5.4 Ray Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.5.5 Ray Therapeutics Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Optogenetic Retinal Gene Therapy Introduction
11.6.4 Novartis Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.6.5 Novartis Recent Development
11.7 UgeneX
11.7.1 UgeneX Company Details
11.7.2 UgeneX Business Overview
11.7.3 UgeneX Optogenetic Retinal Gene Therapy Introduction
11.7.4 UgeneX Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.7.5 UgeneX Recent Development
11.8 GenAns Biotechnology
11.8.1 GenAns Biotechnology Company Details
11.8.2 GenAns Biotechnology Business Overview
11.8.3 GenAns Biotechnology Optogenetic Retinal Gene Therapy Introduction
11.8.4 GenAns Biotechnology Revenue in Optogenetic Retinal Gene Therapy Business (2021–2026)
11.8.5 GenAns Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Optogenetic Retinal Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Light Sensitive Protein
Table 3. Key Players of Light Sensitive Protein Transporter
Table 4. Key Players of Light Stimulation System
Table 5. Global Optogenetic Retinal Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Optogenetic Retinal Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Optogenetic Retinal Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 8. Global Optogenetic Retinal Gene Therapy Market Share by Region (2021–2026)
Table 9. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Optogenetic Retinal Gene Therapy Market Share by Region (2027–2032)
Table 11. Optogenetic Retinal Gene Therapy Market Trends
Table 12. Optogenetic Retinal Gene Therapy Market Drivers
Table 13. Optogenetic Retinal Gene Therapy Market Challenges
Table 14. Optogenetic Retinal Gene Therapy Market Restraints
Table 15. Global Optogenetic Retinal Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 16. Global Optogenetic Retinal Gene Therapy Market Share by Players (2021–2026)
Table 17. Global Top Optogenetic Retinal Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Optogenetic Retinal Gene Therapy Revenue, 2025
Table 18. Ranking of Global Top Optogenetic Retinal Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Optogenetic Retinal Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Optogenetic Retinal Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Optogenetic Retinal Gene Therapy, Products and Applications
Table 22. Global Key Players of Optogenetic Retinal Gene Therapy, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Optogenetic Retinal Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 25. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Type (2021–2026)
Table 26. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Type (2027–2032)
Table 28. Global Optogenetic Retinal Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 29. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Application (2021–2026)
Table 30. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Application (2027–2032)
Table 32. North America Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 34. North America Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. Bionic Sight Company Details
Table 48. Bionic Sight Business Overview
Table 49. Bionic Sight Optogenetic Retinal Gene Therapy Product
Table 50. Bionic Sight Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 51. Bionic Sight Recent Development
Table 52. Nanoscope Therapeutics Company Details
Table 53. Nanoscope Therapeutics Business Overview
Table 54. Nanoscope Therapeutics Optogenetic Retinal Gene Therapy Product
Table 55. Nanoscope Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 56. Nanoscope Therapeutics Recent Development
Table 57. GenSight Biologics Company Details
Table 58. GenSight Biologics Business Overview
Table 59. GenSight Biologics Optogenetic Retinal Gene Therapy Product
Table 60. GenSight Biologics Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 61. GenSight Biologics Recent Development
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Optogenetic Retinal Gene Therapy Product
Table 65. Allergan Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 66. Allergan Recent Development
Table 67. Ray Therapeutics Company Details
Table 68. Ray Therapeutics Business Overview
Table 69. Ray Therapeutics Optogenetic Retinal Gene Therapy Product
Table 70. Ray Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 71. Ray Therapeutics Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Optogenetic Retinal Gene Therapy Product
Table 75. Novartis Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 76. Novartis Recent Development
Table 77. UgeneX Company Details
Table 78. UgeneX Business Overview
Table 79. UgeneX Optogenetic Retinal Gene Therapy Product
Table 80. UgeneX Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 81. UgeneX Recent Development
Table 82. GenAns Biotechnology Company Details
Table 83. GenAns Biotechnology Business Overview
Table 84. GenAns Biotechnology Optogenetic Retinal Gene Therapy Product
Table 85. GenAns Biotechnology Revenue in Optogenetic Retinal Gene Therapy Business (US$ Million), 2021–2026
Table 86. GenAns Biotechnology Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Optogenetic Retinal Gene Therapy Picture
Figure 2. Global Optogenetic Retinal Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Optogenetic Retinal Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Light Sensitive Protein Features
Figure 5. Light Sensitive Protein Transporter Features
Figure 6. Light Stimulation System Features
Figure 7. Global Optogenetic Retinal Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Optogenetic Retinal Gene Therapy Market Share by Application: 2025 vs 2032
Figure 9. Neurological Diseases Case Studies
Figure 10. Retinal Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. Optogenetic Retinal Gene Therapy Report Years Considered
Figure 13. Global Optogenetic Retinal Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Optogenetic Retinal Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Optogenetic Retinal Gene Therapy Market Share by Region: 2025 vs 2032
Figure 16. Global Optogenetic Retinal Gene Therapy Market Share by Players in 2025
Figure 17. Global Optogenetic Retinal Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Optogenetic Retinal Gene Therapy Revenue in 2025
Figure 19. North America Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Optogenetic Retinal Gene Therapy Market Share by Country (2021–2032)
Figure 21. United States Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Optogenetic Retinal Gene Therapy Market Share by Country (2021–2032)
Figure 25. Germany Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Optogenetic Retinal Gene Therapy Market Share by Region (2021–2032)
Figure 33. China Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Optogenetic Retinal Gene Therapy Market Share by Country (2021–2032)
Figure 41. Mexico Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Optogenetic Retinal Gene Therapy Market Share by Country (2021–2032)
Figure 45. Israel Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Optogenetic Retinal Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Bionic Sight Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 49. Nanoscope Therapeutics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 50. GenSight Biologics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 51. Allergan Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 52. Ray Therapeutics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 53. Novartis Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 54. UgeneX Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 55. GenAns Biotechnology Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
